Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

June 20, 2011

Primary Completion Date

November 10, 2017

Study Completion Date

March 17, 2026

Conditions
Breast CarcinomaCarcinoma of Unknown PrimaryEndometrial CarcinomaEsophageal CarcinomaLiver FailureLung CarcinomaMalignant Head and Neck NeoplasmMalignant Testicular NeoplasmMelanomaMetastatic Malignant Solid NeoplasmOvarian CarcinomaRenal FailureUnresectable Malignant NeoplasmUrothelial Carcinoma
Interventions
DRUG

Carboplatin

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Paclitaxel

Given IV

OTHER

Pharmacological Study

Correlative studies

DRUG

Veliparib

Given PO

Trial Locations (17)

10065

Memorial Sloan Kettering Cancer Center, New York

10461

Montefiore Medical Center-Weiler Hospital, The Bronx

10467

Montefiore Medical Center - Moses Campus, The Bronx

15232

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

33612

Moffitt Cancer Center, Tampa

44106

Case Western Reserve University, Cleveland

48201

Wayne State University/Karmanos Cancer Institute, Detroit

53792

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

77030

M D Anderson Cancer Center, Houston

91010

City of Hope Comprehensive Cancer Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

95817

University of California Davis Comprehensive Cancer Center, Sacramento

02215

Dana-Farber Cancer Institute, Boston

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

17033-0850

Penn State Milton S Hershey Medical Center, Hershey

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

National Cancer Institute (NCI)

NIH

NCT01366144 - Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | Biotech Hunter | Biotech Hunter